How Do You Heal Better After PRP? The Cellular Phases of Repair and Why Recovery Protocols Matter

PRP treatment does not end when the injection is completed. The injection initiates a biological process—and what happens during the following days, weeks and months can influence whether that process progresses towards stronger, better-organised tissue or is interrupted before the new matrix has matured.

PRP is not simply an injection

Most discussions about platelet-rich plasma focus on the moment of treatment:

• how much blood is collected;
• how the PRP is prepared;
• how many platelets are delivered; and
• whether the injection is accurately image-guided.

These factors are important. But they are only the beginning.

PRP is intended to initiate and influence a sequence of biological events. Cells must be recruited. Signals must be transmitted. New blood supply may need to develop. Fibroblasts, tenocytes or other repair cells must proliferate. An extracellular matrix must be deposited, organised, loaded and progressively remodelled.

That process cannot be completed during a 30-minute appointment.

The biological response continues for weeks and months. What the patient does during that period—particularly during the first one to two weeks—may affect the environment in which the new tissue is trying to form.

At MBR Health, the treatment pathway is therefore designed around more than injection and short-term pain relief. It is based on:

1. identifying the correct diagnosis;

2. selecting an appropriate biological target;

3. preparing a meaningful PRP product;

4. delivering it accurately under imaging guidance;

5. protecting the early healing response;

6. introducing mechanical load at the appropriate time; and

7. assessing biological and structural recovery, not merely whether pain temporarily improved.

The injection provides the biological signal. Recovery determines what the tissue is able to build from it.

Healing is a sequence, not a single event

Tendon, ligament, muscle and other connective-tissue healing are commonly described in three overlapping phases:

1. Inflammation and cellular signalling

↓

2. Proliferation and early matrix formation

↓

3. Remodelling and maturation.[1–3]

A preliminary haemostatic phase also begins immediately after tissue injury or needle treatment.

These phases do not occur as separate, perfectly defined blocks. They overlap, and their timing varies according to:

• the tissue treated;
• the severity and chronicity of the injury;
• the patient’s age and general health;
• local blood supply;
• smoking;
• diabetes and metabolic health;
• medications;
• the PRP composition and platelet dose;
• injection technique;
• rehabilitation; and
• the mechanical forces placed on the tissue.

A superficial tendon does not heal on the same timetable as an ACL, a degenerated disc, an osteoarthritic joint or a spinal ligament. No single PRP recovery schedule is correct for every procedure.

Nevertheless, understanding the general sequence helps explain why early protection and carefully staged rehabilitation matter.

The 5 Phases of PRP Healing

Phase 1: activation, clot formation and cellular signalling

Approximately the first hours to several days

Platelets are best known for their role in blood clotting, but they are also biological signalling cells.

When platelets are activated, they change shape and release bioactive substances stored within intracellular granules. These include growth factors, cytokines, chemokines and other mediators involved in inflammation, cell migration, angiogenesis and tissue repair.[4–6]

Important signalling molecules associated with PRP include:

• platelet-derived growth factor, or PDGF;
• transforming growth factor beta, or TGF-β;
• vascular endothelial growth factor, or VEGF;
• insulin-like growth factor, or IGF;
• fibroblast growth factor, or FGF;
• epidermal growth factor, or EGF; and
• multiple cytokines and chemotactic mediators.

These signals do not behave like bricks placed directly into a damaged tendon or ligament. They act more like biological instructions.

They may influence nearby cells to:

• migrate towards the injured region;
• proliferate;
• produce collagen and other matrix components;
• develop new microscopic blood vessels;
• regulate inflammation;
• remove damaged material; and
• begin rebuilding the extracellular environment.

A large proportion of preformed platelet growth factors may be released relatively early after activation, but the biological response they initiate continues beyond the initial release period.[4] Platelets, leukocytes, macrophages, fibroblasts, endothelial cells and local progenitor cells participate in an evolving communication network rather than a single burst of activity.

Why some inflammation is expected

PRP is not designed to act like cortisone.

Cortisone suppresses inflammatory activity. PRP is generally intended to initiate or modify a repair response. As a result, patients may experience:

• increased soreness;
• swelling;
• stiffness;
• warmth; or
• temporary aggravation of their familiar symptoms.

This does not mean that more pain always equals more healing. Severe or progressively worsening pain may indicate a complication and requires clinical review. However, a temporary inflammatory response can be an expected part of the early biological process.

Inflammation is not automatically the enemy. Acute, controlled inflammation helps recruit cells and coordinate the transition into tissue repair. The problem is either an inadequate response or inflammation that becomes excessive, prolonged or poorly regulated.[7]

Phase 2: cellular recruitment and proliferation

Beginning within days and continuing through the early weeks

After the initial signalling phase, local repair cells begin to proliferate and migrate into the treated area.

The exact cells involved depend on the tissue:

• tenocytes and tendon progenitor cells in tendons;
• ligament fibroblasts in ligaments;
• chondrocytes and synovial cells in joints;
• muscle satellite cells in muscle;
• annular and disc-related cells in selected spinal treatments;
• endothelial cells involved in new blood-vessel formation; and
• macrophages that help regulate the repair environment.

Laboratory research has found that PRP can influence cell migration, proliferation, viability and collagen production, although the magnitude and direction of these effects vary with platelet concentration, leukocyte content, preparation method and tissue type.[5,8–10]

This variability is important.

“PRP” is not one uniform drug. Two clinics may both advertise PRP while producing biologically different preparations. A low-volume preparation with an unmeasured platelet dose is not necessarily equivalent to a higher-volume, controlled preparation with a known cellular composition.

This is why MBR Health considers:

• the original blood-draw volume;
• the patient’s platelet count;
• expected platelet recovery;
• total platelet dose;
• leukocyte content;
• red-cell contamination;
• preparation technique;
• sterility;
• timing; and
• the tissue being treated.

The objective is not merely to inject something labelled PRP. It is to deliver a biologically meaningful product to the structure that actually requires treatment.

Phase 3: the provisional extracellular matrix

Approximately the first one to six weeks

Cells cannot repair tissue without constructing a scaffold.

This scaffold is the extracellular matrix: the network surrounding cells that provides structural support and helps regulate how cells behave.

Depending on the tissue, the extracellular matrix contains varying combinations of:

• collagen;
• proteoglycans;
• glycosaminoglycans;
• elastin;
• adhesive proteins;
• water; and
• signalling molecules.

During the proliferative phase, fibroblasts and related repair cells begin depositing new matrix. In tendon and ligament healing, the early matrix commonly contains relatively disorganised collagen, including a greater proportion of type III collagen.[1–3]

Type III collagen can be produced relatively quickly and helps bridge a healing area. However, it does not have the same mature organisation and tensile properties as the aligned type I collagen that predominates in healthy tendon and ligament.

The early repair tissue is therefore real—but mechanically immature.

It can be thought of as fresh biological scaffolding:

• cells are present;
• new collagen is being deposited;
• the gap may be beginning to bridge;
• signalling is active; but
• the tissue has not yet developed mature fibre alignment or full load-bearing strength.

This helps explain why pain reduction cannot be used as the only measure of recovery.

A patient may feel substantially better before the new matrix is ready to tolerate sprinting, jumping, heavy lifting, twisting or sudden directional change.

Why the first one to two weeks matter

The early post-PRP period is a vulnerable biological window.

During this period:

• inflammatory and repair signals are being exchanged;
• cells are migrating and proliferating;
• a fibrin-rich provisional environment may be present;
• early collagen and matrix are being deposited; and
• the interface between new and existing tissue remains mechanically immature.

Excessive force during this period may:

• disrupt newly deposited matrix;
• reproduce microtearing;
• increase bleeding or reactive inflammation;
• separate tissue edges that are beginning to bridge;
• interfere with early cellular attachment; or
• repeatedly restart the injury process.

This is why MBR Health may recommend a period of relative rest and protection following selected PRP procedures.

The more severe the structural injury, the more important protection may be.

A mild tendinopathy, osteoarthritic joint and complete ligament rupture should not receive the same instructions. A patient treated for a large partial tear or a ligament gap may require much stricter protection than someone receiving an intra-articular injection for knee osteoarthritis.

Relative protection does not mean doing nothing

Complete and prolonged immobilisation can also be harmful.

Mechanical loading is one of the ways cells learn how to organise new tissue. Through a process known as mechanotransduction, physical force is converted into cellular signals. Appropriate loading can influence:

• cell proliferation;
• collagen synthesis;
• matrix alignment;
• tendon-cell differentiation;
• fibre orientation; and
• the mechanical strength of the healing tissue.[11–14]

Too little load can lead to a poorly organised, weaker matrix. Too much load can cause microdamage or reinjury.

The objective is therefore not permanent rest. It is to use the correct load at the correct biological stage.

In early healing, the tissue needs protection. In later healing, it needs instruction. Mechanical load provides that instruction—but only when the developing matrix is ready to receive it.

Phase 4: matrix organisation and early remodelling

From several weeks onwards

As healing progresses, the initial matrix begins to change.

The tissue gradually transitions from a highly cellular, relatively disorganised repair environment towards a more structured matrix. Collagen fibres become larger, more aligned and more responsive to the direction of mechanical load.

This phase involves both construction and controlled breakdown.

Matrix metalloproteinases and other enzymes help remove damaged or poorly arranged matrix. New collagen is deposited and reorganised. Type III collagen is progressively replaced or supplemented by stronger type I collagen in tissues such as tendons and ligaments.[1–3]

The process is not simply “making more collagen.” Quality depends on:

• which collagen is produced;
• how fibres are cross-linked;
• how they are aligned;
• whether they bridge the correct structure;
• whether the repair is exposed to appropriate load; and
• whether repeated overload disrupts maturation.

This is one reason progressive rehabilitation matters. Controlled loading helps orient collagen along functional lines of stress.

A healing Achilles tendon needs to tolerate tensile loading. A rotator-cuff tendon must eventually respond to traction, compression and rotation. An ACL must ultimately tolerate translation, rotation and change of direction. The rehabilitation stimulus must evolve accordingly.

Phase 5: maturation and functional remodelling

Continuing for months

The final phase of healing can continue for many months.

During maturation:

• collagen fibre diameter may increase;
• collagen cross-linking develops;
• tissue cellularity generally decreases;
• vascularity may normalise;
• fibres become better organised;
• excess matrix is removed; and
• mechanical properties gradually improve.

The tissue that exists at six weeks is not the same as the tissue that exists at six months.

This is why some patients continue to improve well after the early pain response. It is also why a premature return to maximal activity can cause a setback even when symptoms have already settled.

Remodelling is influenced by repeated exposure to load. Rehabilitation progressively teaches the developing tissue what it must be able to do.

A practical framework after PRP

The following is a biological framework rather than a universal prescription. Every patient should follow the instructions provided for their particular procedure.

These periods overlap and vary substantially. They should never be applied without considering the tissue and injury.

With this in mind – MBR Health recommends the following stages after your PRP treatment

Stage 1: protect the biological response

Commonly the first several days

Depending on the procedure, early instructions may include:

• avoiding strenuous use of the treated region;
• avoiding heavy lifting, running, jumping or impact;
• protecting a significant ligament or tendon injury with a brace or support;
• maintaining only the movement specifically permitted;
• avoiding unplanned stretching of a newly treated tear;
• following wound and dressing instructions;
• maintaining adequate hydration and nutrition; and
• using only the pain medication approved by the treating clinician.

The purpose is not to make the patient inactive. It is to avoid overwhelming a biologically active but mechanically vulnerable repair site.

Stage 2: protect the new matrix

Commonly during the remainder of the first one to two weeks

The proliferation phase is underway and early extracellular matrix is being deposited.

For selected structural injuries, MBR Health may recommend continuing to avoid:

• heavy resistance training;
• ballistic movement;
• running or jumping;
• deep stretching;
• high-torque rotation;
• manual therapy directly over the treated tear;
• testing whether the injury has “already healed”; and
• returning to sport simply because pain has improved.

Gentle range of motion, normal daily activity or protected weight-bearing may be appropriate in some cases. Other injuries may require a brace, restricted movement or more specific protection.

The protocol should be determined by the structure treated, not by a generic instruction sheet.

Stage 3: introduce controlled mechanical signalling

Often beginning between approximately one and three weeks

Once the early matrix is sufficiently established, appropriate mechanical load becomes increasingly important.

Rehabilitation may progress through:

• gentle active range of motion;
• isometric loading;
• low-load strengthening;
• controlled concentric exercise;
• later eccentric exercise;
• neuromuscular control;
• proprioception;
• balance;
• joint-specific stability; and
• progressive functional loading.

Research into tendon mechanobiology indicates that both complete unloading and excessive loading can be detrimental. The optimal environment lies between these extremes.[11–14]

This is one reason “rest until it stops hurting” is not an adequate rehabilitation plan. Pain may settle before strength is restored, while persistent low-level discomfort does not always mean healing has stopped.

Stage 4: build capacity, not just comfort

Commonly from six weeks onwards

Later rehabilitation is designed to improve the tissue’s ability to tolerate real-world demand.

Depending on the injury, this may include:

• progressive resistance;
• eccentric and heavy-slow resistance work;
• multiplanar control;
• acceleration and deceleration;
• work-specific movement;
• running progression;
• jumping and landing;
• change of direction;
• sport-specific drills; and
• graded return to full competition.

The aim is not merely to make the tissue painless at rest. It is to build sufficient capacity for the forces the patient will place on it.

Pain relief and healing are not the same outcome

Pain is important, but it is an incomplete measure of tissue recovery.

Pain may decrease because:

• inflammation has reduced;
• a local anaesthetic was used;
• the patient has reduced activity;
• the nervous system is less sensitised;
• the mechanical load has changed; or
• the tissue is genuinely progressing through repair.

Similarly, some discomfort during remodelling does not necessarily mean the tissue has failed.

A treatment model focused only on pain may declare success when the patient feels better for several weeks. A healing-focused model asks additional questions:

• Has the tissue reconnected?
• Has the gap reduced?
• Has fibre continuity improved?
• Has swelling or oedema resolved?
• Has the tendon or ligament regained appropriate tension?
• Has functional stability improved?
• Can the tissue tolerate progressively greater load?
• Does follow-up imaging demonstrate structural change where imaging is clinically justified?

This distinction is central to the MBR Health approach.

Why diagnosis and delivery still come first

No recovery protocol can compensate for treating the wrong structure.

PRP placed into a joint will not repair an untreated extra-articular tendon tear. An injection adjacent to a ligament is not the same as delivery into the injured fibres. Treatment placed generally near the area of pain is not necessarily delivered to the biological target.

This is why MBR Health combines:

• high-resolution diagnostic imaging;
• specialist radiologist interpretation;
• treatment planning based on the pain generator;
• ultrasound or CT guidance selected for the anatomy;
• confirmation and documentation of needle position;
• a measured PRP pathway;
• tissue-specific post-procedure protection; and
• follow-up based on symptoms, function and imaging where appropriate.

You can read more about the importance of PRP dose, preparation and image-guided delivery.

Why PRP protocols cannot be identical

The correct recovery pathway depends on what was treated.

PRP for osteoarthritis

An intra-articular knee injection may permit relatively early gentle movement because complete immobilisation is generally unnecessary and joint motion can support normal joint function.

PRP for tendinopathy

A chronically degenerated tendon usually requires progressive mechanical loading. However, the timing and intensity should reflect whether the tendon was injected, fenestrated or treated at an insertion.

PRP for a partial tendon tear

A structurally disrupted tendon may need a longer period of protection than uncomplicated tendinopathy. Early loading must avoid propagating the tear.

PRP for ligament injury

A ligament that is bridging a gap may require bracing or restriction of movements that repeatedly separate the healing fibres. Later rehabilitation must restore stability, strength and proprioception.

PRP for an ACL rupture

The early priority may include protecting the developing continuity from anterior translation and rotational stress. Returning to pivoting activity because the knee feels better could disrupt biologically immature tissue.

Spinal PRP

Epidural, facet-related, ligamentous, perineural and intradiscal PRP are different treatments. Each has a different anatomical target, risk profile and recovery pathway.

A universal “rest for two days and return to normal” instruction cannot adequately cover this range.

Why avoiding anti-inflammatory medication is critical

Patients are instructed to avoid non-steroidal anti-inflammatory drugs, or NSAIDs, around PRP treatment.

The rationale is that PRP depends partly on platelet activity and a controlled inflammatory response. Some NSAIDs can affect platelet aggregation, activation or growth-factor release, although their effects vary according to the medication, dose and timing.

However, medication should never be stopped without considering why it was prescribed.

This is particularly important for:

• aspirin prescribed for cardiovascular protection;
• antiplatelet therapy after a coronary procedure;
• anticoagulant medication;
• patients with clotting disorders; and
• patients at elevated cardiovascular or thrombotic risk.

Any medication change should be approved by the prescribing doctor and the treating clinician.

Does stronger inflammation mean better healing?

Not necessarily. A stronger post-treatment flare may reflect a more intense biological response, a more severe underlying injury, leukocyte content, the tissue treated or the degree of needle intervention. It does not automatically predict a better outcome.

Healing depends on a regulated sequence. Too little signalling may fail to stimulate repair, while excessive or persistent inflammation may promote matrix degradation and poor tissue quality.

The objective is not maximum inflammation. It is an effective transition from inflammation to proliferation and then to organised remodelling.

Documenting healing – not merely reporting pain scores

MBR Health has reported selected cases in which structural change has been documented with serial imaging, including MRI-documented continuity following complete ACL injury and advanced image-guided PRP applications.

These cases are important because they demonstrate what can be measured when treatment is designed around anatomy, biology and follow-up—not because a case report proves that every patient will obtain the same result. PRP is relatively new to many and is still considered an experimental treatment (despite having large bodies of comprehensive research in some applications) – for this reason MBR Health utilises imaging and quantitative imaging measurments where possible to document and quantify improvement.

Traditionally, many non-operative pain treatments have been assessed predominantly by:

• pain scores;
• temporary symptom improvement;
• medication use; or
• time until another procedure is required.

MBR Health is interested in a more demanding question:

Has the tissue itself changed?

Where clinically appropriate, structural assessment may include:

• MRI evidence of fibre continuity;
• reduction in a tear or defect;
• quantitative analysis of pulmonary improvement;
• change in oedema or inflammation;
• restoration of ligament morphology;
• ultrasound evidence of tendon organisation;
• change in joint effusion or synovitis; and
• correlation between imaging, stability and function.

Published case reports and serial imaging do not replace controlled clinical trials. They do, however, allow unusual or emerging structural outcomes to be transparently documented and investigated.

The appropriate claim is not that standard medicine never achieves healing. Many tissues heal naturally, and conventional rehabilitation is fundamental to recovery. Rather, MBR Health’s protocols are specifically designed to optimise and measure healing in selected injuries where spontaneous structural recovery may otherwise be considered limited, unpredictable or uncommon.

Why some PRP treatments fail

Failure does not always mean that “PRP does not work.”

Potential reasons include:

• the diagnosis was incorrect;
• the wrong structure was treated;
• the treatment was not accurately delivered;
• the platelet dose was too low;
• the PRP composition was inappropriate for the tissue;
• the injury was mechanically incapable of healing;
• there was excessive early loading;
• the tissue was immobilised for too long;
• rehabilitation was poorly timed;
• smoking, diabetes or metabolic disease impaired recovery;
• the patient returned to sport too early;
• the injury was too chronic or retracted;
• important instability or malalignment was not corrected; or
• surgery was the more appropriate treatment.

PRP cannot overcome every mechanical problem. A severely retracted tendon, gross instability, advanced tissue loss or major neurological compression may require surgery.

Good regenerative medicine includes knowing when not to offer a regenerative procedure.

The MBR Health healing framework

The MBR Health PRP pathway can be summarised as:

1. Diagnose the tissue

Pain is a symptom. The tendon, ligament, joint, disc, nerve or other structure responsible must be identified.

2. Determine whether it can heal

Not every abnormality has sufficient tissue viability, vascular access, mechanical stability or biological capacity for repair.

3. Deliver a meaningful biological dose

The treatment should account for platelet number, blood-draw volume, recovery, cellular composition and the size of the target.

4. Reach the target precisely

Ultrasound, CT or another imaging strategy is selected according to the anatomy—not simply according to which machine is available.

5. Protect early matrix formation

The first one to two weeks may be critical in significant tendon and ligament injuries. Relative protection reduces the risk of disrupting newly forming tissue.

6. Introduce load at the correct stage

Mechanical loading is progressively introduced so that cells and collagen receive the signals required for organisation and strength.

7. Measure more than pain

Symptoms, function, stability and structural imaging are considered together where follow-up imaging will meaningfully change management.

The central message

PRP is not an instant repair material. It is a biological stimulus that may help coordinate the patient’s own healing response. That response still requires time, appropriate tissue selection, adequate biological dose, accurate placement, early protection and progressively applied mechanical load.

The early matrix is not yet mature tissue. Feeling better does not mean it is ready for unrestricted force.

This is why the recovery protocol is not an administrative afterthought at MBR Health. It is part of the treatment.

We do not simply inject PRP and wait to see whether the pain improves. We identify the tissue, define the biological target, deliver a meaningful dose, protect the early matrix and then progressively load the repair. Our objective is not only pain relief—it is measurable recovery wherever the biology and anatomy make healing possible.

— Dr Zane Sherif, Specialist Radiologist

Frequently asked questions

How long should I rest after PRP?

It depends on the structure treated and the severity of the injury. Some joint procedures permit early gentle movement, while significant tendon or ligament injuries may require one to two weeks of relative protection or a longer period of bracing. Complete prolonged rest is not appropriate for every condition.

Why can returning to exercise too early be harmful?

During the early proliferative phase, cells are depositing a new extracellular matrix. This matrix is initially disorganised and mechanically weaker than mature tissue. Excessive force may produce microdamage or disrupt fibres that are beginning to bridge the injury.

Does that mean I should not move at all?

Usually not. Prolonged unloading can impair matrix production, cell alignment and tissue strength. The aim is controlled, stage-appropriate movement and loading—not complete inactivity or unrestricted exercise.

When does physiotherapy start after PRP?

Published protocols vary considerably. A systematic review found that stretching was commonly commenced within two to seven days and strengthening within two to three weeks, but protocols differed substantially.[15] The correct timing depends on the tissue, injury and procedure.

When does new collagen form after PRP?

Cellular proliferation and matrix production begin during the early days and weeks. Initial collagen is relatively immature and disorganised. Organisation, conversion towards stronger matrix and functional remodelling continue for months.

How long does PRP healing take?

Some symptom change may occur within weeks, but tendon and ligament remodelling commonly continues for several months. Complex ligament, spinal and tendon injuries may require longer.

Can I return to sport when the pain stops?

Not necessarily. Pain can improve before tissue strength, proprioception and load capacity have returned. Return to sport should be based on the treated structure, functional testing, rehabilitation progress and clinical review—not pain alone.

Should I avoid NSAIDs after PRP?

Many PRP protocols limit NSAIDs because of their effects on platelet function and inflammation. However, medication instructions vary, and prescribed aspirin, antiplatelet or anticoagulant medication must not be stopped without approval from the relevant doctors.

Does more pain after PRP mean it is working better?

No. Temporary soreness may be expected, but the intensity of pain is not a reliable measure of healing. Severe, progressive or unexpected symptoms require clinical review.

Can MRI or ultrasound prove that PRP worked?

Follow-up imaging can sometimes demonstrate structural changes such as improved fibre continuity, reduced oedema or altered tendon morphology. Imaging should be interpreted with symptoms, examination and function. Not every clinical improvement produces a visible imaging change, and not every imaging change proves that PRP caused it.

Related MBR Health articles

• Platelet-Rich Plasma
• Pain and Injury
• Tendon, Ligament and Muscle Injury
• Joint Pain and Osteoarthritis
• Back and Neck Pain
• Regenerative Medicine Research
• MBR Health Publications

References

1. Müller SA, Todorov A, Heisterbach PE, Martin I, Majewski M. Tendon healing: an overview of physiology, biology, and pathology of tendon healing and systematic review of state of the art in tendon bioengineering. Knee Surg Sports Traumatol Arthrosc. 2015 Jul;23(7):2097-105. doi: 10.1007/s00167-013-2680-z. Epub 2013 Sep 21. PMID: 24057354.

2. Hope M, Saxby TS. Tendon healing. Foot Ankle Clin. 2007 Dec;12(4):553-67, v. doi: 10.1016/j.fcl.2007.07.003. PMID: 17996614.

3. Leong NL, Kator JL, Clemens TL, James A, Enamoto-Iwamoto M, Jiang J. Tendon and Ligament Healing and Current Approaches to Tendon and Ligament Regeneration. J Orthop Res. 2020 Jan;38(1):7-12. doi: 10.1002/jor.24475. Epub 2019 Sep 30. PMID: 31529731; PMCID: PMC7307866.

4. Pavlovic V, Ciric M, Jovanovic V, Stojanovic P. Platelet Rich Plasma: a short overview of certain bioactive components. Open Med (Wars). 2016 Aug 12;11(1):242-247. doi: 10.1515/med-2016-0048. PMID: 28352802; PMCID: PMC5329835.

5. Qian Y, Han Q, Chen W, Song J, Zhao X, Ouyang Y, Yuan W, Fan C. Platelet-Rich Plasma Derived Growth Factors Contribute to Stem Cell Differentiation in Musculoskeletal Regeneration. Front Chem. 2017 Oct 31;5:89. doi: 10.3389/fchem.2017.00089. PMID: 29164105; PMCID: PMC5671651.

6. Everts P, Onishi K, Jayaram P, Lana JF, Mautner K. Platelet-Rich Plasma: New Performance Understandings and Therapeutic Considerations in 2020. Int J Mol Sci. 2020 Oct 21;21(20):7794. doi: 10.3390/ijms21207794. PMID: 33096812; PMCID: PMC7589810.

7. Landén NX, Li D, Ståhle M. Transition from inflammation to proliferation: a critical step during wound healing. Cell Mol Life Sci. 2016 Oct;73(20):3861-85. doi: 10.1007/s00018-016-2268-0. Epub 2016 May 14. PMID: 27180275; PMCID: PMC5021733.

9. de Mos M, van der Windt AE, Jahr H, van Schie HT, Weinans H, Verhaar JA, van Osch GJ. Can platelet-rich plasma enhance tendon repair? A cell culture study. Am J Sports Med. 2008 Jun;36(6):1171-8. doi: 10.1177/0363546508314430. Epub 2008 Mar 7. PMID: 18326832.

10. Hudgens JL, Sugg KB, Grekin JA, Gumucio JP, Bedi A, Mendias CL. Platelet-Rich Plasma Activates Proinflammatory Signaling Pathways and Induces Oxidative Stress in Tendon Fibroblasts. Am J Sports Med. 2016 Aug;44(8):1931-40. doi: 10.1177/0363546516637176. Epub 2016 Jul 8. PMID: 27400714; PMCID: PMC4970921.

11. Killian ML, Cavinatto L, Galatz LM, Thomopoulos S. The role of mechanobiology in tendon healing. J Shoulder Elbow Surg. 2012 Feb;21(2):228-37. doi: 10.1016/j.jse.2011.11.002. PMID: 22244066; PMCID: PMC3259533.

12. Wang JH, Guo Q, Li B. Tendon biomechanics and mechanobiology–a minireview of basic concepts and recent advancements. J Hand Ther. 2012 Apr-Jun;25(2):133-40; quiz 141. doi: 10.1016/j.jht.2011.07.004. Epub 2011 Sep 17. PMID: 21925835; PMCID: PMC3244520.

13. Lavagnino M, Wall ME, Little D, Banes AJ, Guilak F, Arnoczky SP. Tendon mechanobiology: Current knowledge and future research opportunities. J Orthop Res. 2015 Jun;33(6):813-22. doi: 10.1002/jor.22871. Epub 2015 Apr 27. PMID: 25763779; PMCID: PMC4524513.

14. Hammerman M, Pierantoni M, Isaksson H, Eliasson P. Deprivation of loading during rat Achilles tendon healing affects extracellular matrix composition and structure, and reduces cell density and alignment. Sci Rep. 2024 Oct 8;14(1):23380. doi: 10.1038/s41598-024-74783-w. PMID: 39379568; PMCID: PMC11461875.

15. Townsend C, Von Rickenbach KJ, Bailowitz Z, Gellhorn AC. Post-Procedure Protocols Following Platelet-Rich Plasma Injections for Tendinopathy: A Systematic Review. PM R. 2020 Sep;12(9):904-915. doi: 10.1002/pmrj.12347. Epub 2020 Apr 6. PMID: 32103599.

16. Neph A, Schroeder A, Enseki KR, Everts PA, Wang JH, Onishi K. Role of Mechanical Loading for Platelet-Rich Plasma-Treated Achilles Tendinopathy. Curr Sports Med Rep. 2020 Jun;19(6):209-216. doi: 10.1249/JSR.0000000000000719. PMID: 32516191; PMCID: PMC8898381.

Medical disclaimer: This article provides general educational information and is not an individual rehabilitation prescription. PRP evidence and recovery protocols vary significantly by indication, preparation and tissue. Patients must follow the instructions given by their treating clinician. PRP does not guarantee pain relief, structural healing or avoidance of surgery. New weakness, fever, progressive swelling, neurological symptoms or severe unexpected pain requires prompt medical assessment.

Advanced Pain Relief and Regenerative Treatment on the Gold Coast

For patients seeking advanced pain relief, PRP treatment and regenerative medicine on the Gold Coast or within easy reach of Brisbane, MBR Health provides a specialist, diagnosis-led alternative to routine injection clinics. Our approach combines research-grade 3T MRI, advanced Spectral CT, specialist radiologist assessment, high-dose PRP and precise ultrasound- or CT-guided delivery to identify and treat the structure actually responsible for pain. Rather than focusing only on temporary symptom relief, our protocols are designed around the biology of tissue healing—from accurate diagnosis and meaningful platelet dose to early protection, progressive rehabilitation and follow-up imaging where appropriate. Led by specialist radiologist Dr Zane Sherif, MBR Health offers one of Australia’s most advanced image-guided pathways for spinal pain, joint pain, osteoarthritis, tendon injury, ligament damage and complex musculoskeletal conditions. Patients travel to our Mermaid Beach clinic from across the Gold Coast, Brisbane, Logan, northern New South Wales and wider South East Queensland when they are looking for expert imaging, precision-guided pain treatment and a genuine regenerative strategy focused on recovery – not simply masking pain.